Home > Market > Market Stats >  IOL Chemicals & Pharmaceuticals

IOL Chemicals & Pharmaceuticals

Sector: Chemical Manufacturing
Powered by
348.85 +2.60 (0.75%)
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y

Price Range

Today’s Low 334.75
Today’s High 350.2
52 Week Low 295.1
52 Week High 625.0

Key Metrics

  • Market Cap (In Cr) 2029.74
  • Beta 1.5
  • Div. Yield (%) 1.16
  • P/B 1.46
  • TTM P/E 14.09
  • Peg Ratio 0.22
  • Sector P/E 24.66
  • D/E -
  • Open Price 334.75
  • Prev Close 346.25
View All Metrics on Mint Genie

Analysis

Price Analysis
  • 1 Week
    -5.29%
  • 3 Months
    6.43%
  • 6 Month
    -2.25%
  • YTD
    -28.45%
  • 1 Year
    -38.71%
Risk Meter
  • 49% Low risk
  • 49% Moderate risk
  • 49% Balanced Risk
  • 49% High risk
  • 49% Extreme risk
Recos
2 Analysts
  • Strong Sell
  • Sell
  • Hold
  • Buy
  • Strong Buy
Analysts' Views
  • Ratings
  • Current
  • Strong Sell
  • 0
  • Sell
  • 0
  • Hold
  • 0
  • Buy
  • 0
  • Strong Buy
  • 2

IOL Chemicals & Pharmaceuticals News

View More News

Financials

  • INCOME
  • BALANCE SHEET
  • Cashflow
  • Period
  • 2022
  • Total Revenue
  • 2184.02
  • Selling/ General/ Admin Expenses Total
  • 303.42
  • Depreciation/ Amortization
  • 43.26
  • Other Operating Expenses Total
  • 24.54
  • Total Operating Expense
  • 1981.81
  • Operating Income
  • 202.21
  • Net Income Before Taxes
  • 224.85
  • Net Income
  • 167.67
  • Diluted Normalized EPS
  • 30.47
  • Period
  • 2021
  • Total Revenue
  • 1966.98
  • Selling/ General/ Admin Expenses Total
  • 235.83
  • Depreciation/ Amortization
  • 38.92
  • Other Operating Expenses Total
  • 14.97
  • Total Operating Expense
  • 1413.89
  • Operating Income
  • 553.09
  • Net Income Before Taxes
  • 571.39
  • Net Income
  • 444.56
  • Diluted Normalized EPS
  • 76.23
  • Period
  • 2020
  • Total Revenue
  • 1894.47
  • Selling/ General/ Admin Expenses Total
  • 224.11
  • Depreciation/ Amortization
  • 35.73
  • Other Operating Expenses Total
  • 11.8
  • Total Operating Expense
  • 1356.29
  • Operating Income
  • 538.18
  • Net Income Before Taxes
  • 533.24
  • Net Income
  • 361.29
  • Diluted Normalized EPS
  • 63.51
  • Period
  • 2019
  • Total Revenue
  • 1685.33
  • Selling/ General/ Admin Expenses Total
  • 197.85
  • Depreciation/ Amortization
  • 32.45
  • Other Operating Expenses Total
  • 10.84
  • Total Operating Expense
  • 1308.09
  • Operating Income
  • 377.24
  • Net Income Before Taxes
  • 336.15
  • Net Income
  • 236.7
  • Diluted Normalized EPS
  • 42.11
  • Period
  • 2018
  • Total Revenue
  • 1000.96
  • Selling/ General/ Admin Expenses Total
  • 56.1
  • Depreciation/ Amortization
  • 30.21
  • Other Operating Expenses Total
  • 111.29
  • Total Operating Expense
  • 910.54
  • Operating Income
  • 90.42
  • Net Income Before Taxes
  • 31.3
  • Net Income
  • 27.7
  • Diluted Normalized EPS
  • 5.1
  • Period
  • 2017
  • Total Revenue
  • 773.19
  • Selling/ General/ Admin Expenses Total
  • 43.18
  • Depreciation/ Amortization
  • 29.84
  • Other Operating Expenses Total
  • 87.67
  • Total Operating Expense
  • 700.63
  • Operating Income
  • 72.56
  • Net Income Before Taxes
  • 5.93
  • Net Income
  • 4.67
  • Diluted Normalized EPS
  • 0.85
View detailed financials on Mint Genie

Forecast

Income Sheet (In Cr) Net Income Vs Revenue
Returns Metrics (In Cr) ROA Vs ROE

Technical

Moving Average SMA
  • 5 Day355.28
  • 10 Day365.02
  • 20 Day369.99
  • 50 Day364.56
  • 100 Day357
  • 300 Day394.61

Peers

  • Price
  • Ratio
  • Name
  • Latest Price
  • Change
  • % Change
  • 52W High
  • 52W Low
  • Mkt. Cap

Corporate Actions

  • Board Meeting
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
  • Meeting Date
  • Purpose
  • 09-Aug-22
  • Quarterly Results
  • 30-May-22
  • Quarterly Results
  • 04-Feb-22
  • Quarterly Results & Interim Dividend
  • 12-Nov-21
  • Quarterly Results
  • 13-Aug-21
  • Quarterly Results
  • 04-Jun-21
  • Audited Results
  • 10-Feb-21
  • Quarterly Results

Company Profile

ABOUT IOL Chemicals & Pharmaceuticals

  • Industry Chemical Manufacturing
  • ISIN INE485C01011
  • BSE Code 524164
  • NSE Code IOLCP

IOL Chemicals and Pharmaceuticals Limited is an India-based generic pharmaceutical company. The Company is engaged in manufacturing and selling of organic chemicals, specialty, intermediates, and bulk drugs. Its product portfolio covers various therapeutic categories, such as Pain Management, Anti-diabetic, Anti-hypertensive, and Anti-convulsant, amongst others. Its active pharma ingredients (API) product portfolio include Ibuprofen, Ibuprofen Lysinate, Ibuprofen Sodium, Dex-Ibuprofen, Metformin HCL, Clopidogrel Bisulphate (Form II), Pantoprazole Sodium, Fenofibrate, Gabapentin, Lamotrigine, Ursodeoxycholic Acid, Losartan Potassium and Levetiracetam. Its specialty chemical division include Ethyl Acetate, Iso Butyl Benzene, Acetyl Chloride and Mono Chloro Acetic Acid. The Company caters to the pharmaceutical and specialty chemical requirements across both domestic and international markets. It serves Austria, Belgium, Hungry, Spain, Germany, Italy, Netherlands, Switzerland and others.

MANAGEMENT

  • Sanjay Chaturvedi Chief Executive Officer, Executive Director
  • Pardeep Khanna Chief Financial Officer
  • Abhay Singh Vice President, Company Secretary
  • Varinder Gupta Managing Director, Executive Director
  • Vikas Gupta Executive Director
  • Kushal Rana Director - Works

Company Summary

IOL CHEMICALS & PHARMACEUTICALS SUMMARY

IOL Chemicals & Pharmaceuticals is trading 0.75% upper at Rs 348.85 as compared to its last closing price. IOL Chemicals & Pharmaceuticals has been trading in the price range of 350.2 & 334.75. IOL Chemicals & Pharmaceuticals has given -28.45% in this year & -5.29% in the last 5 days.

 

IOL Chemicals & Pharmaceuticals has TTM P/E ratio 14.09 as compared to the sector P/E of 24.66. There are 2 analysts who have initiated coverage on IOL Chemicals & Pharmaceuticals. There are 2 analysts who have given it a strong buy rating & 0 analysts have given it a buy rating. 0 analysts have given the stock a sell rating.

 

The company posted a net profit of 34.67 Crores in its last quarter.

 

Listed peers of IOL Chemicals & Pharmaceuticals include Vishnu Chemicals (3.54%), Thirumalai Chemicals (1.18%), IOL Chemicals & Pharmaceuticals (0.75%) etc.

FAQs about IOL Chemicals & Pharmaceuticals

IOL Chemicals & Pharmaceuticals is trading at 348.85 as on 30 Sep, 2022 11:52:41 AM. This is 0.75% upper as compared to its previous closing price of 346.25
The market capitalization of IOL Chemicals & Pharmaceuticals is 2029.74 Cr as on 30 Sep, 2022 11:52:41 AM.
The average broker rating on IOL Chemicals & Pharmaceuticals is Strong Buy. The breakup of analyst rating is given below -
  • 0 analysts have given a strong sell rating
  • 0 analysts have given a sell rating
  • 0 analysts have given a hold rating
  • 0 analysts have given a buy rating
  • 2 analysts have given a strong buy rating
The 52 wk high for IOL Chemicals & Pharmaceuticals is 625.0 whereas the 52 wk low is 295.1
IOL Chemicals & Pharmaceuticals can be analyzed on the following key metrics -
  • TTM P/E: 14.09
  • Sector P/E: 24.66
  • Dividend Yield: 1.16%
  • D/E ratio: -
IOL Chemicals & Pharmaceuticals reported a net profit of 167.67 Cr in 2022.

Recommended For You

Trending Stocks

×
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout